Home / Inspections / 1231342

FDA Inspection 1231342 — Sagent Pharmaceuticals

Sagent Pharmaceuticals — FEI 3006167046

The FDA completed an inspection of Sagent Pharmaceuticals on September 20, 2024 in Schaumburg, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 20, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Schaumburg, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1114257 (VAI Wed Dec 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1066792 (VAI Mon Sep 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 940865 (NAI Wed Aug 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 782558 (VAI Fri May 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 717757 (NAI Fri Mar 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources